Silexion Therapeutics
SLXN • XNAS • Stock Fundamentals
Silexion Therapeutics is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Ilan Hadar, with a market cap of $1.8M.
Market Cap$1.8M
CEOIlan Hadar
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Silexion Therapeutics FAQ
Common questions about Silexion Therapeutics
Silexion Therapeutics (SLXN) has a market capitalization of $1.8M and trades on XNAS.